Remove Competition Remove Government Remove Healthcare Provider Remove Prescription
article thumbnail

What health plans should know about healthcare price transparency

Clarify Health

No surprise billing: A breakdown of the key requirements and deadlines in the No Surprises Act The No Surprises Act aims to protect patients from receiving “surprise” (or unexpected) medical bills from a healthcare provider or facility after inadvertently receiving care from an out-of-network provider.

article thumbnail

How to Choose a Good Healthcare CRM

Referral MD

It seeks to optimize the way we establish and nurture meaningful and sustainable relationships in efforts to enhance patient experience, improve population health, reduce costs and improve the work life of healthcare providers – ultimately leading to increased trust in and loyalty to the organization. Enhance patient experience.

CRM 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents. Novartis vs Greece.

article thumbnail

Uri Goren

Cadensee

But also governing from a business side; our platforms, our technologies, what is employed, trying to create a much more global digital backbone that supports all of these different use cases in the different countries. But in terms of Israel as a competitive advantage, I think data is much more than just good technology.

article thumbnail

Legal challenges put off label use of gender affirming care drugs in jeopardy

Pharmaceutical Technology

The laws proposed in several bills range in their potential influence; from restricting the prescription of gender-affirming drugs to criminalising the use of such drugs to allowing states to pursue lawsuits against parents who allow children to access such treatments. Generally, individuals first take on social gender-affirmation changes.

Ethics 144